H5N1 targets pulmonary cells in humans, study finds

01/20/2012 | InfectionControlToday.com

Scientists at the CDC and the University of South Alabama found that the highly pathogenic avian influenza strain H5N1 damages pulmonary endothelial cells by causing inflammation, leading to acute respiratory distress syndrome that is fatal in 60% of humans infected with H5N1. Other influenza strains do not target the endothelial cells in the same way. In light of these findings, anti-inflammatory medications may have a role in treating H5N1 infections, though scientists emphasize that combination therapies would be most effective.

View Full Article in:

InfectionControlToday.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC